Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors
Improved VSV-G variants with a better on/off-target ratio as attractive tools for in vivo gene therapy applications are presented.
We have 2 of 2 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Improved VSV-G variants with a better on/off-target ratio as attractive tools for in vivo gene therapy applications are presented.
Lentiviral vectors have revolutionized gene therapy by efficient and stable transduction of dividing and non-dividing cells, their large packaging capacity, and their compatibility with pseudotyping to alter viral tropism. The vesicular stomatitis virus glycoprotein (VSV-G) is widely used as a viral envelope protein of...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.